Total Payments
$1,869
2024 Payments
$348.25
Companies
15
Transactions
72
Medicare Patients
3,959
Medicare Billing
$786,516
Payment Breakdown by Category
Food & Beverage$1,724 (92.3%)
Education$122.79 (6.6%)
Gifts$21.33 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,724 | 62 | 92.3% |
| Education | $122.79 | 9 | 6.6% |
| Gift | $21.33 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $681.32 | 30 | $0 (2024) |
| Melinta Therapeutics, LLC | $321.08 | 12 | $0 (2024) |
| Shionogi Inc | $315.52 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $118.26 | 1 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $117.73 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $107.96 | 1 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $36.45 | 2 | $0 (2024) |
| Theravance Biopharma, Inc. | $34.93 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $24.99 | 1 | $0 (2017) |
| ABBVIE INC. | $21.73 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $348.25 | 14 | Bayer Healthcare Pharmaceuticals Inc. ($117.73) |
| 2023 | $132.14 | 5 | Shionogi Inc ($80.42) |
| 2022 | $516.40 | 23 | Merck Sharp & Dohme LLC ($222.54) |
| 2021 | $27.69 | 2 | Merck Sharp & Dohme Corporation ($27.69) |
| 2020 | $97.99 | 7 | Merck Sharp & Dohme Corporation ($64.39) |
| 2019 | $598.02 | 12 | Merck Sharp & Dohme Corporation ($299.21) |
| 2018 | $75.72 | 5 | Merck Sharp & Dohme Corporation ($27.56) |
| 2017 | $72.30 | 4 | Astellas Pharma US Inc ($24.99) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Rezzayo | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: ANTIBIOTICS | ||||||
| 09/27/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: ANTIBIOTIC | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $117.73 | General |
| Category: Cardio-renal | ||||||
| 09/13/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/30/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ANTIBIOTIC | ||||||
| 07/22/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/10/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/05/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: ANTIFUNGALS | ||||||
| 03/01/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/23/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ANTIFUNGALS | ||||||
| 01/08/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/17/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: ANTIBIOTICS | ||||||
| 08/15/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo, Vabomere | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: ANTIBIOTICS | ||||||
| 05/15/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/28/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/13/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Infections and Infectious Diseases | ||||||
| 12/12/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/19/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ANTIBIOTICS | ||||||
| 11/14/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/31/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/12/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: ANTIBIOTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 901 | 2,324 | $496,250 | $173,186 |
| 2022 | 7 | 1,000 | 3,053 | $655,200 | $206,827 |
| 2021 | 6 | 857 | 2,664 | $571,600 | $180,687 |
| 2020 | 8 | 1,201 | 3,232 | $714,050 | $225,817 |
Total Patients
3,959
Total Services
11,273
Medicare Billing
$786,516
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 324 | 1,196 | $239,000 | $76,229 | 31.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 316 | 649 | $162,250 | $62,265 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 99 | $19,800 | $7,783 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 140 | $21,000 | $7,454 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 63 | $18,900 | $6,628 | 35.1% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 20 | 60 | $9,000 | $2,904 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 27 | $5,400 | $2,715 | 50.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,800 | $2,314 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $6,300 | $2,261 | 35.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 35 | $5,250 | $1,408 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $2,550 | $1,224 | 48.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 358 | 1,798 | $359,600 | $103,640 | 28.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 250 | 627 | $156,750 | $51,844 | 33.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 192 | 194 | $58,200 | $21,106 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 74 | 267 | $40,050 | $14,577 | 36.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 43 | $17,200 | $6,884 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 32 | 32 | $9,600 | $3,523 | 36.7% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 23 | 59 | $8,850 | $2,892 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 33 | $4,950 | $2,360 | 47.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 367 | 1,755 | $351,000 | $102,779 | 29.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 233 | 550 | $137,500 | $46,433 | 33.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 167 | 171 | $51,150 | $18,956 | 37.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 36 | 97 | $14,550 | $5,493 | 37.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $6,000 | $2,441 | 40.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 32 | $4,800 | $2,339 | 48.7% |
About Dr. Nabil Khoury, M.D
Dr. Nabil Khoury, M.D is a Infectious Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053366351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nabil Khoury, M.D has received a total of $1,869 in payments from pharmaceutical and medical device companies, with $348.25 received in 2024. These payments were reported across 72 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,724).
As a Medicare-enrolled provider, Khoury has provided services to 3,959 Medicare beneficiaries, totaling 11,273 services with total Medicare billing of $786,516. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Houston, TX
- Active Since 05/24/2006
- Last Updated 09/30/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1053366351
Products in Payments
- ZERBAXA (Drug) $402.22
- Fetroja (Drug) $315.52
- Kimyrsa (Drug) $205.84
- DIFICID (Drug) $162.17
- Vascepa (Drug) $118.26
- Kerendia (Drug) $117.73
- RECARBRIO (Drug) $116.93
- Biktarvy (Drug) $107.96
- Orbactiv (Drug) $72.59
- Rezzayo (Drug) $42.65
- NUZYRA (Drug) $36.45
- VIBATIV (Drug) $34.93
- AVYCAZ (Drug) $21.73
- SUPREP BOWEL PREP (Drug) $21.33
- INTRAROSA (Drug) $20.56
- REBYOTA (Biological) $17.73
- PICO (Device) $17.62
- LILETTA (Drug) $11.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Houston
Dr. Richard Hamill, M.d, M.D
Infectious Disease — Payments: $883,001
Infectious Disease $883,001
Roy Chemaly, M.d, M.D
Infectious Disease — Payments: $815,305
Infectious Disease $815,305
Dr. Joseph Gathe, M.d, M.D
Infectious Disease — Payments: $774,683
Infectious Disease $774,683
Ben Barnett, M.d, M.D
Infectious Disease — Payments: $515,688
Infectious Disease $515,688
Dr. Amar Safdar, M.d, M.D
Infectious Disease — Payments: $309,168
Infectious Disease $309,168
Dr. Luis Ostrosky, M.d, M.D
Infectious Disease — Payments: $242,843
Infectious Disease $242,843